Correction to: Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy

Authors:

Published: 2023-12-18

DOI: 10.1093/eurheartj/ehad854

Source: Full article

Abstract

No abstract found.